| 59400 | In this global service, the provider and nonphysician healthcare providers in the practice provide all of the antepartum care, admission to the hospital for delivery, labor management, including… | 53 | 80 | 100 | $1,260 | $405.3K |
| 76811 | The provider performs an ultrasound study using a transabdominal approach to examine the fetus and mother, along with additional examination of the fetal anatomy, such as the heart rate, amniotic… | 26 | 60 | 320 | $140 | $346.9K |
| 76819 | The provider performs a biophysical profile test to measure the health of the baby during pregnancy using only ultrasound and not a nonstress test. | 23 | 100 | 670 | $60 | $342.9K |
| 76820 | The provider performs Doppler ultrasonography for fetal surveillance to determine the velocity of blood flow through the umbilical artery. This test determines the timing of labor induction and when… | 10 | 50 | 490 | $50 | $333.3K |
| 76816 | The provider reexamines the fetus to follow up on a prior abnormal transabdominal ultrasound. | 33 | 150 | 390 | $60 | $220.9K |
| 43239 | The provider inserts a flexible endoscope through the mouth and down into the esophagus, stomach, and duodenum where he removes one or more tissue biopsy specimens for diagnostic analysis. | 2 | 170 | 340 | $190 | $206.8K |
| 90460 | In this procedure, the provider administers a single live attenuated vaccine through a parenteral, oral, intranasal, intramuscular, or intravenous to a patient up to 18 years of age. | 295 | 610 | 1,220 | $40 | $206K |
| 99214 | The provider sees an established patient for an office visit or other outpatient visit involving evaluation and management. The visit involves a moderate level of medical decision making, and/or the… | 25 | 3,760 | 610 | $40 | $202.3K |
| 99213 | The provider sees an established patient for an office visit or other outpatient visit involving evaluation and management. The visit involves a low level of medical decision making, and/or the… | 49 | 4,050 | 620 | $30 | $183.9K |
| 87428 | The lab analyst performs an immunoassay to qualitatively or semiquantitatively evaluate the patient specimen for antigens of severe acute respiratory syndrome (SARS) coronavirus, such as SARS–CoV–2… | 105 | 130 | 370 | $50 | $183.3K |